Troy Bremer

Troy is co-founder and Chief Scientific Officer at PreludeDx and has been an integral part of the company since its inception.

Troy is passionate about improving healthcare through innovation. His research background has involved the application of machine learning, statistical pattern recognition, modeling and biostatistics to molecular biology. He has expertise in the planning, management, analysis and execution of complex research and development programs.

Troy has extensive experience in diagnostic development and previously identified and validated several biomarker panels for disease prognosis and treatment response in oncology leading to a number of publications and various patents. Prior to PreludeDx, Troy worked at Lion Biosciences and Prediction Sciences where he served at Director of Research and Development.

Troy received his Doctorate in Biomedical Engineering from the University of California, San Diego.